Choi implanter DHI evidence begins with a device, not with a separate way of obtaining donor hair. In contemporary clinic language, “DHI” commonly describes placement of prepared follicular-unit grafts with a Choi-style implanter pen. The instrument can combine a recipient puncture with delivery of a graft at a chosen angle and depth. It may be useful in an organised, carefully selected workflow, but it does not create additional donor follicles, diagnose the cause of hair loss, or make any result automatic.
That distinction is essential when interpreting Choi implanter DHI evidence. The early Korean literature described a practical instrument for placing small grafts. Modern DHI advertising can bundle that instrument with claims about “no touch,” unshaven treatment, maximum density, faster recovery, or guaranteed survival. Those claims concern different surgical steps and different outcomes. A meaningful comparison asks what happens during extraction, storage, recipient-site design and implantation—not simply which acronym appears on a quotation.
The 1992 Korean paper behind the Choi implanter
In 1992, Yung Chul Choi and Jung Chul Kim, writing from a clinic in Seoul, Korea, published Single hair transplantation using the Choi hair transplanter. The paper presented a new procedure for single-hair transplantation and described potential cosmetic uses in hairline refinement and reconstruction of eyebrows, eyelashes, beard and pubic hair. Its historical importance is specific: it placed a Korean-developed implanter into the peer-reviewed surgical conversation at a time when small grafts were becoming increasingly important for natural-looking restoration.
The paper should not be read as proof that every modern treatment sold as DHI is the same procedure, nor that the original device solved every recipient-area problem. Hair-transplant terminology has expanded since 1992, and multiple sharp and dull needle implanter designs now exist. Still, the core idea remains recognisable: load a prepared graft into a needle-based instrument, introduce the instrument at the planned position, and deploy the graft while controlling depth and direction.
This was a meaningful development because small single-hair grafts are particularly useful where the eye notices transitions: the leading hairline, temple points, brows and selected scar edges. Yet the device did not replace the anatomical principles that determine whether those grafts look natural. Hairline shape, graft choice, angle, direction, spacing, existing hair and future hair loss remain planning decisions. An implanter is a placement tool within that larger plan.
What an implanter changes during surgery
A sharp Choi-style implanter contains a graft within a fine needle or lumen. After loading, the operator brings the needle to the recipient scalp, creates an opening as it enters and advances a plunger or introducer to leave the graft in place. In a classic sharp-needle workflow, incision and placement are closely coupled. By contrast, a premade-slit workflow creates recipient sites first and subsequently places grafts with forceps or with an implanter adapted to those sites. “Stick and place” is another workflow in which a site is made and a graft is placed immediately.
These are real procedural differences, but they are not simple rankings. The recipient-area review by Marwah and Mysore describes density, distribution and arrangement, and angulation and direction as central implantation principles. Those principles can be applied with forceps, premade sites or an implanter. A pen may help an experienced operator execute a chosen angle and depth; it does not independently decide which angle is appropriate for a patient’s frontal hairline, crown whorl, temple or scar.
Nor does an implanter determine how grafts were obtained. In many DHI-labelled scalp procedures, follicular units are harvested using FUE before they are loaded and placed. FUE is a donor-harvest method; an implanter is a recipient-placement instrument. Our review of the 2002 FUE FOX Procedure explains why individual extraction has its own donor assessment, transection and distribution constraints. Calling a procedure DHI does not remove those extraction decisions.
Why “direct” is an imprecise word
“Direct hair implantation” sounds as though a graft travels straight from donor scalp to recipient scalp without intermediate handling. In practice, grafts are still extracted, inspected, sorted when necessary, loaded into instruments and placed by a coordinated team. Some protocols create sites in advance; others use a sharp implanter to make the opening and place the graft in the same movement. The word direct therefore does not define one universal sequence, device, storage interval or staffing model.
This ambiguity is visible in the 2013 case series called Direct Hair Transplantation. Sethi and Bansal described 29 FUE patients in whom recipient sites were made first and extraction and implantation were then performed in a coordinated, near-immediate workflow. The study is useful for understanding why teams try to reduce time outside the body and unnecessary handling. It is not a controlled trial proving that every procedure marketed as DHI, or every implanter pen, produces better survival than other carefully performed placement methods.
The terminology question resembles the distinction between follicular unit “extraction” and “excision”: a familiar label may conceal several steps. Our article on follicular unit extraction versus excision unpacks the donor-side terminology. For DHI, the patient should ask the corresponding recipient-side question: are sites created in advance, with a sharp implanter, or by a combined approach, and who is responsible for each step?
Graft handling: a plausible advantage is not a guaranteed outcome
Follicular grafts are living tissue while outside the scalp. A review by Parsley and Perez-Meza identifies basics that can influence growth and survival, including gentle handling, hydration, temperature and time out of body. The surgical logic behind implanters is understandable: if a workflow reduces repeated forceps contact or organises extraction and placement efficiently, it may reduce opportunities for drying, crushing or delay.
But a mechanism is not the same as a patient-specific result. An implanter must be loaded correctly, the needle must suit the graft and recipient tissue, and insertion must be gentle and correctly oriented. Poor loading, excessive force, unsuitable depth, dull instruments, a rushed team or an inappropriate recipient plan can offset the theoretical benefit. Equally, a careful forceps-based or premade-site workflow can protect grafts well. Graft survival is affected by the entire chain of care, not by the final instrument alone.
This is why “no touch” needs qualification. A Choi-style device may reduce direct forceps contact with part of a graft during final insertion, depending on the workflow. It does not mean the graft has never been handled, that its bulb cannot be damaged, or that a person’s growth rate has been guaranteed. A responsible explanation identifies the handling steps, quality checks and storage process rather than turning a shorthand phrase into a biological promise.
What the published implanter studies actually show
Direct evidence exists, but it is narrower than broad DHI claims suggest. A 2001 study of 11 patients used the KNU implanter to compare one-hair with two-hair follicular units in small marked recipient templates. The investigators reported hair-count survival figures at six and twelve months, including a 92% mean total-hair survival figure at six months. It is a valuable early study of a defined device, graft type and population. It was not a large head-to-head trial against forceps placement, and its result cannot be converted into a universal DHI survival promise.
A 2019 observational study by Bansal and colleagues described 104 FUE patients treated with implanters in premade recipient slits while extraction and placement proceeded in parallel. The authors reported clinical improvement in many patients and proposed that the approach could reduce handling and time outside the body. Crucially, the article explicitly noted that it did not objectively measure regrowth and it did not compare outcomes between placement methods. Its practical description is useful; its design cannot establish that implanters are universally denser, safer or superior.
These limitations are not a criticism of using an implanter. They are an argument for proportionate claims. A patient may reasonably prefer a team that can explain why an implanter suits a small hairline, work among existing hairs or a particular graft mix. The same patient should be cautious of statements that a pen alone guarantees survival, eliminates trauma, permits unlimited packing or replaces a donor assessment.
Recipient sites, density and naturalness still require clinical judgement
Recipient-area planning starts before an instrument touches the scalp. The clinician must decide which zones deserve priority, how much donor reserve can safely be allocated, what density is realistic, whether native hair is vulnerable, and how the pattern may evolve. A leading edge may need carefully selected single-hair units and soft irregularity; a mid-scalp or crown may need a different distribution, direction and density strategy. Those choices are not encoded in a DHI label.
Needle diameter, graft size, scalp characteristics and spacing matter as well. An incision that is too small can compress a graft; an incision or placement that is poorly angled can lead to unnatural emergence; very aggressive packing can challenge tissue and complicate placement. The recipient-area literature discusses multiple implanter sizes and the use of different sizes for different graft types. That is a practical reminder that “one pen” is an oversimplification of a tailored procedure.
Powered extraction and computer assistance are likewise separate questions. Our research on motorized FUE punch control and robotic FUE examines tools used during donor harvesting. They may affect workflow, but neither determines the recipient-site plan. A sound consultation separates the donor tool, the site-creation method, the placement method and the quality-control process instead of presenting all four as one proprietary “technique.”
Does DHI mean no shaving, faster healing or more density?
No-shave or partially shaven treatment is a planning choice, not an automatic consequence of a Choi implanter. Long existing hair can make recipient access and placement more technically demanding, while donor harvesting must still be performed safely and with adequate visibility. A smaller treatment area, hair characteristics, graft count and team workflow may make a partial-shave plan feasible for one person and impractical for another.
Early healing also follows the same basic graft-wound biology as other scalp transplant procedures. Redness, swelling, crusting, tenderness, temporary shedding and variable hair-growth timing can still occur. An implanter does not make a transplant painless, scarless or free of shock loss. Patients should follow their own treating team’s postoperative instructions and seek clinical advice for escalating pain, spreading redness, drainage, fever or another unexpected change.
Density is constrained by donor supply, recipient-area size, hair calibre, contrast, curl, native-hair status, tissue safety and long-term loss. A pen can be part of a precise placement workflow; it cannot manufacture donor reserve or make unsafe density safe. The practical DHI hair transplant guide explains these day-to-day questions alongside recovery and consultation planning, while the DHI operation overview describes the site’s procedure scope.
Questions that make a DHI proposal more transparent
Ask which extraction method will be used, whether recipient sites are premade or created by a sharp implanter, and why that sequence fits your hair and scalp. Ask who designs the hairline, who makes recipient sites or inserts the implanter, who loads grafts and who has authority to reduce the graft count or change the plan if donor or recipient conditions require it.
Ask how grafts are kept hydrated, how long they are expected to be outside the body, how damaged grafts are identified, and how the team protects native hair. A reliable answer can acknowledge uncertainty and individual variation. Our review of graft survival, storage and handling explains why those questions apply to the whole workflow, not only to the final pen. A technology-focused answer that never discusses donor reserve, diagnosis, future hair loss or the responsible clinician is incomplete.
Finally, ask what outcome the clinic means when it says “better.” Does it mean less forceps contact, a particular placement workflow, a small case series, an internal photograph set or a measured comparative result? The evidence should match the claim. This is more useful than choosing between acronyms alone.
For the narrower comparison that is often obscured by the acronym, read our review of DHI versus premade-slits implanter evidence. It explains why some studies use implanters in sites made in advance rather than treating the two approaches as opposites.
Limits of the evidence
Implanter research includes technical reports, small studies and observational series that use different devices, graft types, patient populations, recipient areas and outcome measures. Many studies do not directly compare sharp implanter, premade-slit and forceps approaches under the same conditions. Few can isolate the effect of the pen from extraction quality, team experience, graft storage, site design and patient biology.
The evidence supports a cautious conclusion: Choi-style implanters are established placement instruments with a clear historical origin and a reasonable surgical rationale. It does not support a claim that DHI is a wholly separate donor-harvest technique, a no-touch guarantee, a no-shave guarantee, or the best method for every patient. Good outcomes still depend on diagnosis, donor preservation, recipient design, atraumatic handling, accountable supervision and realistic long-term planning.
Conclusion
Choi implanter DHI evidence is most useful when it is read as evidence about a recipient-placement tool and workflow—not a magic replacement for hair-transplant fundamentals. The 1992 Korean paper introduced an influential way to place small grafts, and later studies provide valuable practical observations. They do not erase the need to evaluate the whole operation. A well-explained DHI plan tells a patient what the pen changes, what it does not change, who performs each step and what cannot responsibly be promised.
For a comparison that places implanters beside the other commonly marketed labels, read FUE, DHI and Sapphire technique-label evidence. It explains why an implanter does not replace donor-harvest assessment or recipient-site planning.
